Spots Global Cancer Trial Database for hypofractionated radiotherapy (bladder only)
Every month we try and update this database with for hypofractionated radiotherapy (bladder only) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992) | NCT04241185 | Urinary Bladder... | Pembrolizumab Conventional Ra... Conventional Ra... Hypofractionate... Cisplatin Fluorouracil (5... Mitomycin C (MM... Gemcitabine Placebo to Pemb... | 18 Years - | Merck Sharp & Dohme LLC | |
Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992) | NCT04241185 | Urinary Bladder... | Pembrolizumab Conventional Ra... Conventional Ra... Hypofractionate... Cisplatin Fluorouracil (5... Mitomycin C (MM... Gemcitabine Placebo to Pemb... | 18 Years - | Merck Sharp & Dohme LLC |